2342 — TransGenic Balance Sheet

0.000.00%

Last trade - 00:00

Consumer CyclicalsHighly SpeculativeMicro CapNeutral

Annual balance sheet for TransGenic, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	4,624	3,459	2,478	2,555	2,135
Net Total Accounts Receivable
Net Total Receivables	893	1,076	1,336	1,212	1,165
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	7,710	7,562	6,550	6,699	6,709
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,993	1,992	2,142	2,055	1,960
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	10,441	10,673	9,811	9,586	9,735
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2,659	2,744	2,434	3,272	3,848
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	3,908	4,655	3,917	4,824	4,955
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	6,533	6,018	5,894	4,763	4,780
Total Liabilities & Shareholders' Equity	10,441	10,673	9,811	9,586	9,735
Total Common Shares Outstanding